Overview
Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess safety of Omnipure inj. (lohexol) contrast media in CT scanning patientsAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Criteria
Inclusion Criteria:- subjects in need of CT scanning
- subjects who signed up informed consent
Exclusion Criteria:
- Known allergy or hypersensitivity to the study medication, ingredient of the
medication, and Iodine type medication
- severe renal insufficiency patients
- severe hypothyroidism
- severe local infection or bacteremia